• REGENXBIO Inc. (RGNX) Stock Price | Live Quotes & Charts | NASDAQ timothysykes.com Thu, 09 Jul 2026 23:29:47 GMT
• (rgnx) movement as an input in quant signal sets Stock Traders Daily Thu, 09 Jul 2026 16:40:01 GMT
• Sarepta Hits Fresh Hurdle As Court Revives Patent Lawsuit With Regenxbio Over Muscular Disorder Therapy Stocktwits Wed, 08 Jul 2026 08:59:58 GMT
• First Patient Dosed in Phase 2b/3 NAAVIGATE Trial of Gene Therapy Surabgene Lomparvovec in Diabetic Retinopathy CGTLive® Tue, 07 Jul 2026 11:14:23 GMT
• Regenxbio CMO Steve Pakola sells $29,476 in common stock Investing.com Tue, 07 Jul 2026 03:47:36 GMT
• Form 4 Regenxbio Inc For: 6 July By Investing.com Investing.com South Africa Mon, 06 Jul 2026 21:33:59 GMT
• Regenxbio CMO Steve Pakola sells $29,476 in common stock By Investing.com Investing.com Canada Mon, 06 Jul 2026 21:00:26 GMT
• REGENXBIO (RGNX) CEO logs ESPP share acquisitions and tax-withholding stock disposition Stock Titan Mon, 06 Jul 2026 20:52:17 GMT
• REGENXBIO (RGNX) CMO Pakola exercises options and sells 2,161 shares under plan Stock Titan Mon, 06 Jul 2026 20:51:59 GMT
• REGENXBIO (RGNX) completes employee option exchange, grants 775,401 replacement options Stock Titan Mon, 06 Jul 2026 12:02:26 GMT
• rgnx shareholder alert: bronstein, gewirtz and grossman, llc anno The National Law Review Sun, 05 Jul 2026 02:29:16 GMT
• rgnx investor alert: bronstein, gewirtz and grossman, llc reminds The National Law Review Sat, 04 Jul 2026 06:40:33 GMT
• rgnx shareholder alert: bronstein, gewirtz and grossman, llc anno The National Law Review Thu, 02 Jul 2026 10:42:28 GMT
• regenxbio insider sold shares worth $688,756, according to a recent sec filing marketscreener.com Thu, 02 Jul 2026 08:28:46 GMT
• form 4 regenxbio inc for: 1 july by investing.com Investing.com Canada Thu, 02 Jul 2026 01:12:34 GMT
• Regenxbio CMO Steve Pakola sells $688,755 in company stock. Investing.com Thu, 02 Jul 2026 00:34:46 GMT
• Regenxbio Chief Medical Officer Sold Shares Worth Over $688K TradingView Thu, 02 Jul 2026 00:10:00 GMT
• proposed 43,206-share sale for rgnx (nasdaq: rgnx) tied to option exercise Stock Titan Wed, 01 Jul 2026 20:32:37 GMT
• h.c. wainwright reiterates regenxbio stock rating on trial milestone by investing.com Investing.com South Africa Wed, 01 Jul 2026 14:19:17 GMT
• REGENXBIO (RGNX) amends Schedule TO to update employee option exchange content Stock Titan Wed, 01 Jul 2026 13:12:47 GMT
• h.c. wainwright maintains regenxbio(rgnx.us) with buy rating, maintains target price $26 Moomoo Wed, 01 Jul 2026 12:31:00 GMT
• REGENXBIO doses first patient in NAAVIGATE, phase 2b/3 sura-vec trial for diabetic retinopathy Ophthalmology Times Europe Tue, 30 Jun 2026 19:19:38 GMT
• regenxbio inc.(nasdaqgs: rgnx) added to russell small cap comp growth benchmark marketscreener.com Mon, 29 Jun 2026 20:48:27 GMT
• regenxbio inc.(nasdaqgs: rgnx) added to russell 2500 growth benchmark marketscreener.com Mon, 29 Jun 2026 19:27:46 GMT
• fda opens path to approval for hunter syndrome gene therapy Progress Educational Trust Mon, 29 Jun 2026 16:09:24 GMT
• regenxbio says first patient dosed in phase iib/iii naavigate trial TipRanks Mon, 29 Jun 2026 11:50:57 GMT
• regenxbio inc.(nasdaqgs: rgnx) added to russell 2000 growth benchmark marketscreener.com Mon, 29 Jun 2026 10:44:12 GMT
• REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company... Yahoo Finance Mon, 29 Jun 2026 07:00:00 GMT
• $100M AbbVie payment backs REGENXBIO (RGNX) Phase IIb/III eye gene therapy Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• regenxbio doses first patient in eye-disease gene therapy trial Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• regenxbio doses first patient in diabetic retinopathy trial Investing.com Mon, 29 Jun 2026 07:00:00 GMT
• regenxbio inc.(nasdaqgs: rgnx) added to russell 3000e growth benchmark marketscreener.com Mon, 29 Jun 2026 04:16:01 GMT
• regenxbio upgraded to strong buy after fda eases requirements for rare disease therapy navsunli Pluang Sun, 28 Jun 2026 15:39:10 GMT
• Regenxbio: 'Strong Buy' On FDA Course Reversal For NAVSUNLI And Potential AA DMD Filing Seeking Alpha Sun, 28 Jun 2026 07:00:00 GMT
• enterprise value to ebitda forward of regenxbio inc. – nasdaq:rgnx TradingView Sat, 27 Jun 2026 20:25:01 GMT
• enterprise value to revenue forward of regenxbio inc. – nasdaq:rgnx TradingView Sat, 27 Jun 2026 17:42:16 GMT
• enterprise value to revenue forward of regenxbio, inc. – mun:rb0 TradingView Sat, 27 Jun 2026 13:54:05 GMT
• enterprise value to ebitda forward of regenxbio, inc. – mun:rb0 TradingView Sat, 27 Jun 2026 13:37:24 GMT
• what’s next in line for fda reversals after uniqure and regenxbio MSN Sat, 27 Jun 2026 10:36:14 GMT
• regenxbio shares rise on plans to resubmit navsunli bla for mps ii MSN Sat, 27 Jun 2026 10:32:11 GMT
• price to earnings forward of regenxbio inc. – nasdaq:rgnx TradingView Sat, 27 Jun 2026 04:17:23 GMT
• AbbVie Acquires Apogee, FDA Changes Tune on RegenxBio, & Merck Seizes TL1A Lead Timmerman Report Fri, 26 Jun 2026 03:14:42 GMT
• fda commissioner refers to rare disease drug with associated morbidity: analysts are divided if makary meant regenxbio or uniqure’... Stocktwits Fri, 26 Jun 2026 01:42:58 GMT
• fda clears path for navsunli bla resubmission in mps ii, no additional studies required NeurologyLive Thu, 25 Jun 2026 17:48:41 GMT
• morgan stanley maintains regenxbio(rgnx.us) with buy rating, maintains target price $16 Moomoo Thu, 25 Jun 2026 11:34:00 GMT
• Regenxbio completes dosing in Duchenne gene therapy study The Pharma Letter Thu, 25 Jun 2026 07:00:00 GMT
• FDA’s uniQure, REGENXBIO reversals could bolster other near-term rare disease applications BioSpace Thu, 25 Jun 2026 07:00:00 GMT
• H.C. Wainwright reiterates Regenxbio stock rating on trial completion Investing.com Thu, 25 Jun 2026 07:00:00 GMT
• usfda signals accelerated approval route for regenxbio's navsunli after earlier rejection Medical Dialogues Thu, 25 Jun 2026 06:37:21 GMT
• apogee-abbvie; regenxbio and fda news; spacex decline | stock movers bella vaughn hunter johnson engagement (caxfnfiejq) Mshale Thu, 25 Jun 2026 04:46:23 GMT
• Feeling bullish over FDA changes, Regenxbio solidifies filing plans for Duchenne gene therapy FirstWord Pharma Thu, 25 Jun 2026 01:09:36 GMT
• regenxbio inc. (rgnx) stock price | live quotes & charts | nasdaq StocksToTrade Thu, 25 Jun 2026 00:39:00 GMT
• rgnx reiterated by hc wainwright & co. -- price target maintained at $26 GuruFocus Wed, 24 Jun 2026 18:12:32 GMT
• what’s next in line for fda reversals after uniqure and regenxbio Seeking Alpha Wed, 24 Jun 2026 16:38:33 GMT
• regenxbio (rgnx) advances gene therapy for duchenne muscular dys GuruFocus Wed, 24 Jun 2026 13:30:00 GMT
• regenxbio - completes dosing in rgx-202 confirmatory study TradingView Wed, 24 Jun 2026 11:27:46 GMT
• REGENXBIO Completes Dosing in Confirmatory Study of RGX-202, Marking Completion of Registrational Development Program and Supporti... PR Newswire Wed, 24 Jun 2026 11:05:00 GMT
• fda commissioner refers to rare disease drug with associated morbidity: analysts are divided if makary meant regenxbio or uniqure’... Stocktwits Wed, 24 Jun 2026 07:41:50 GMT
• Wagering on FDA changes, Regenxbio will submit Duchenne gene therapy for approval STAT Wed, 24 Jun 2026 07:00:00 GMT
• REGENXBIO bets on FDA flexibility with filing plans for Duchenne gene therapy BioSpace Wed, 24 Jun 2026 07:00:00 GMT
• Regenxbio completes dosing in gene therapy study for Duchenne Investing.com Wed, 24 Jun 2026 07:00:00 GMT
• REGENXBIO clears key Duchenne study step, aims for BLA filing in Q3 Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• regenxbio inc. announces alignment with fda on path forward for rgx-121 bla resubmission for accelerated approval marketscreener.com Tue, 23 Jun 2026 18:29:00 GMT
• h.c. wainwright keeps their buy rating on regenxbio (rgnx) The Globe and Mail Tue, 23 Jun 2026 14:07:14 GMT
• regenxbio focuses on accelerating gene therapy development for duchenne community at orlando event Traders Union Tue, 23 Jun 2026 13:40:38 GMT
• regenxbio reaches fda deal on accelerated approval for hunter syndrome drug Новости GxP Tue, 23 Jun 2026 12:04:24 GMT
• key facts: fda reconsiders regenxbio; july meeting, q3 bla resub TradingView Tue, 23 Jun 2026 07:13:31 GMT
• Regenxbio Shares Rise on Plans to Resubmit Navsunli BLA for MPS II Yahoo Finance Tue, 23 Jun 2026 07:00:00 GMT
• FDA changes rare disease tune again as it clears path for Regenxbio’s gene therapy Yahoo Finance Tue, 23 Jun 2026 07:00:00 GMT
• Regenxbio rises after FDA clears path for Hunter syndrome gene therapy resubmission The Pharma Letter Tue, 23 Jun 2026 07:00:00 GMT
• H.C. Wainwright reiterates Regenxbio stock rating on FDA pathway Investing.com Tue, 23 Jun 2026 07:00:00 GMT
• us fda reverses course on regenxbio's rare-disease gene therapy, backs accelerated approval bid ETPharma.com Tue, 23 Jun 2026 01:36:35 GMT
• us fda reverses course on regenxbio’s rare-disease gene therapy, backs accelerated approval bid by reuters Investing.com Tue, 23 Jun 2026 00:45:05 GMT
• regenxbio inc. (rgnx) stock price | live quotes & charts | nasdaq StocksToTrade Tue, 23 Jun 2026 00:43:00 GMT
• in another fda rethink, door opens for regenxbio's gene therapy comeback FirstWord Pharma Tue, 23 Jun 2026 00:23:17 GMT
• in another fda rethink, door opens for regenxbio gene therapy filing comeback FirstWord PHARMA Tue, 23 Jun 2026 00:23:17 GMT
• regenxbio’s gene therapy latest example of fda’s reversion to the mean BioCentury Mon, 22 Jun 2026 23:31:00 GMT
• regenxbio gets breath of fresh air from us fda for navsunli in mps ii Citeline News & Insights Mon, 22 Jun 2026 20:56:54 GMT
• regenxbio (rgnx) gains approval for accelerated review of gene t GuruFocus Mon, 22 Jun 2026 18:54:28 GMT
• recon: abbvie forges $10.9 billion deal with apogee; us fda changes tack on regenxbio's rare disease gene therapy RAPS.org Mon, 22 Jun 2026 17:56:00 GMT
• regenxbio (rgnx) receives fda alignment for navsunli resubmissio GuruFocus Mon, 22 Jun 2026 15:23:38 GMT
• REGENXBIO to resubmit application for Hunter gene therapy after FDA’s most recent pivot BioSpace Mon, 22 Jun 2026 14:39:49 GMT
• h.c. wainwright maintains regenxbio(rgnx.us) with buy rating, maintains target price $26 Moomoo Mon, 22 Jun 2026 14:32:00 GMT
• In another reversal for rare disease field, FDA to reconsider Regenxbio gene therapy Fierce Biotech Mon, 22 Jun 2026 14:26:41 GMT
• fda agrees to expedited review of regenxbio's gene therapy navsunli for rare hunter syndrome Pluang Mon, 22 Jun 2026 14:07:17 GMT
• regenxbio (rgnx) secures fda pathway for navsunli accelerated ap GuruFocus Mon, 22 Jun 2026 13:57:26 GMT
• regenxbio (rgnx) stock surges following fda decision on gene the GuruFocus Mon, 22 Jun 2026 13:52:30 GMT
• regenxbio gains fresh chance as fda reconsiders gene therapy - regenxbio (nasdaq:rgnx) Benzinga Mon, 22 Jun 2026 13:23:14 GMT
• rgnx: regenxbio inc latest stock price, analysis, news and trading ideas Stocktwits Mon, 22 Jun 2026 13:06:24 GMT
• regenxbio aligns with fda for potential accelerated approval of navsunli TradingView Mon, 22 Jun 2026 11:42:39 GMT
• regenxbio: duchenne data keeps me bullish, there's less room for setbacks now Seeking Alpha Mon, 22 Jun 2026 11:30:13 GMT
• REGENXBIO Announces Alignment with FDA on Path Forward for NAVSUNLI™ BLA Resubmission for Accelerated Approval; First Potential Ge... PR Newswire Mon, 22 Jun 2026 11:30:00 GMT
• regenxbio shares up on wsj report of fda u-turn on company's gene therapy marketscreener.com Mon, 22 Jun 2026 11:20:15 GMT
• regenxbio tells wsj that fda will reverse rejection of drug TipRanks Mon, 22 Jun 2026 11:14:45 GMT
• Regenxbio to resubmit Hunter syndrome gene therapy as FDA rare disease about-face continues Endpoints News Mon, 22 Jun 2026 11:14:00 GMT
• why is regenxbio stock surging today? by investing.com Investing.com Nigeria Mon, 22 Jun 2026 11:08:14 GMT
• fda will reverse rejection of third rare-disease drug, regenxbio says -- wsj Moomoo Mon, 22 Jun 2026 11:02:26 GMT
• fda to reverse rejection of regenxbio's rare-disease drug, wsj reports TradingView Mon, 22 Jun 2026 10:54:44 GMT
• US FDA reverses course on Regenxbio's rare-disease gene therapy, backs accelerated approval bid Reuters Mon, 22 Jun 2026 07:00:00 GMT
• Exclusive | FDA Gives Third Rare-Disease Drug Another Shot, Regenxbio Says WSJ Mon, 22 Jun 2026 07:00:00 GMT
• Regenxbio to resubmit gene therapy as FDA backtracks on another drug rejection BioPharma Dive Mon, 22 Jun 2026 07:00:00 GMT
• FDA reverses course on Regenxbio’s childhood gene therapy after rejection STAT Mon, 22 Jun 2026 07:00:00 GMT
• RGNX Retail Investors See Hope As FDA Reopens Door For Regenxbio’s Hunter Syndrome Therapy Stocktwits Mon, 22 Jun 2026 07:00:00 GMT
• REGENXBIO Inc. Stock 12‑Month Price Target Raised to $26.08, Implies 234% Upside TradingView Mon, 22 Jun 2026 07:00:00 GMT
• AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock Movers Yahoo Finance Mon, 22 Jun 2026 07:00:00 GMT
• Regenxbio aligns with FDA on gene therapy resubmission path Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• US FDA reverses course on Regenxbio’s rare-disease gene therapy, backs accelerated approval bid By Reuters Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• baird raises regenxbio stock price target on fda refiling nod Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• regenxbio: duchenne data keeps me bullish; there's less room for setbacks now Seeking Alpha Mon, 22 Jun 2026 07:00:00 GMT
• watch abbvie's deal with apogee; regenxbio moves on gene therapy drug | stock movers Bloomberg.com Mon, 22 Jun 2026 07:00:00 GMT
• leerink raises regenxbio stock price target on fda pathway clarity Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• regenxbio inc (rgnx) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 18:55:29 GMT
• why is regenxbio stock surging today? by investing.com Investing.com South Africa Wed, 17 Jun 2026 18:13:19 GMT
• fda commissioner refers to rare disease drug with associated morbidity: analysts are divided if makary meant regenxbio or uniqure’... Stocktwits Wed, 17 Jun 2026 17:49:37 GMT
• why (rgnx) price action is critical for tactical trading Stock Traders Daily Wed, 17 Jun 2026 14:20:01 GMT
• regenxbio inc (rgnx) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 10:20:09 GMT
• regenxbio inc (rgnx) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 10:16:46 GMT
• Regenxbio stock gains after FDA's UniQure U-turn (RGNX:NASDAQ) Seeking Alpha Wed, 17 Jun 2026 07:00:00 GMT
• Are Options Traders Betting on a Big Move in REGENXBIO Stock? Yahoo Finance Tue, 16 Jun 2026 07:00:00 GMT
• regenxbio to host webcast on may 14 to discuss topline results from pivotal trial of rgx-202 for duchenne muscular dystrophy Eastern Progress Mon, 15 Jun 2026 05:10:00 GMT
• regenxbio (rgnx) expected to beat earnings estimates: can the stock move higher? Eastern Progress Sun, 14 Jun 2026 22:25:33 GMT
• fda commissioner refers to rare disease drug with associated morbidity: analysts are divided if makary meant regenxbio or uniqure’... Stocktwits Sun, 14 Jun 2026 14:21:32 GMT
• diabetic retinopathy market set for strong expansion through 2036 amid rising investment interest – delveinsight | genentech, ioni... Barchart Fri, 12 Jun 2026 00:54:12 GMT
• regenxbio inc. (rgnx) edges higher as gene therapy pipeline awaits key catalysts - ichimoku kumo break newsline.com Mon, 08 Jun 2026 23:46:17 GMT
REGENXBIO Inc(NASDAQ:RGNX) 
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates ...
Website: http://www.regenxbio.com
Founded: 2008
Full Time Employees: 257
Sector: Healthcare
Industry: Biotechnology